Research Tool

« Go back to Research tools

Anti-CtBP1 [CG14] Antibody

The technology

CtBP1 functions as a transcriptional compressor. CtBPs regulates epithelial to mesenchymal transition and cell metabolism. Due to the unavailability of commercial antibodies against human C-terminal-binding protein 1 (CtBP1), inventors at Virginia Commonwealth University have developed mouse monoclonal antibodies against this protein. Successful screening of the antibodies were performed by Western Blot (WB) analysis using CtBP1-His and the human ovarian cancer cell line SKOV3 as a source of material. The antibodies were also successfully tested in immunoprecipitation assays (IP), immunofluorescence cell staining (IHC), and chromatin immunoprecipitation assays (ChIP).

  •  Antigen/Gene or Protein Targets
    • CtBP1 (does not cross-react with CtBP2)
  •  Reactivity
    • Human
  •  Host
    • Mouse
  •  Immunogen
    • Full length protein C-terminal 6xHis-tag
  • Subclass
    • IgG2a kappa

 

 

VCU Innovation Gateway is responsible for commercializing VCU research. We are commited to enhancing the overall culture of innovation and entrepreneurship at VCU and contributing to the growth of the region’s innovation ecosystem. This broader mission fosters collaborations with local and prospective companies to build external support for our inventors, and grows an entrepreneurial population to help us commercialize our technologies through new venture creation and thus support economic growth of our region.

VCU Innovation Gateway
Virginia Commonwealth University
800 E. Leigh St, Suite 3000
Box 980568
Richmond, VA 23298-0568

www.innovationgateway.vcu.edu
ott@vcu.edu
(804) 828-5188